Interleukin-6 mediates resistance to PI3K-pathway–targeted therapy in lymphoma
Joo Hyun Kim(Samsung (South Korea)), Chaehwa Park(Samsung Medical Center)
Cited by 51
Related Papers
E2F-1 is a critical modulator of cellular senescence in human cancer
|International Journal of Molecular Medicine|2006|54